Search Results
Search for other papers by Srividya Vasu in
Google Scholar
PubMed
Search for other papers by Mary K McGahon in
Google Scholar
PubMed
Search for other papers by R Charlotte Moffett in
Google Scholar
PubMed
Search for other papers by Tim M Curtis in
Google Scholar
PubMed
Search for other papers by J Michael Conlon in
Google Scholar
PubMed
Search for other papers by Yasser H A Abdel-Wahab in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Introduction Incidence of type 2 diabetes is constantly on the rise, owing to an increase in consumption of a Western diet, sedentary lifestyle, obesity and ageing population ( Stumvoll et al. 2008 , McCarthy 2011 ). Current therapies
Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic
Search for other papers by Anna Cinkajzlová in
Google Scholar
PubMed
Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Search for other papers by Miloš Mráz in
Google Scholar
PubMed
Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Search for other papers by Martin Haluzík in
Google Scholar
PubMed
2010 ). Excessive accumulation of VAT phenotypically presented as android obesity is associated with higher metabolic risk and the development of insulin resistance, arterial hypertension, type 2 diabetes mellitus (T2DM) and cardiovascular diseases
Search for other papers by Gary A Wittert in
Google Scholar
PubMed
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Search for other papers by Bu B Yeap in
Google Scholar
PubMed
Search for other papers by David J Handelsman in
Google Scholar
PubMed
reversible with weight loss ( Grossmann 2018 ) and does not demonstrate androgen deficiency. Although weight loss will both increase serum testosterone and prevent type 2 diabetes (T2D), it is unclear whether this effect is mediated directly by the increase
Search for other papers by G Üçkaya in
Google Scholar
PubMed
Search for other papers by P Delagrange in
Google Scholar
PubMed
Search for other papers by A Chavanieu in
Google Scholar
PubMed
Search for other papers by G Grassy in
Google Scholar
PubMed
Search for other papers by M-F Berthault in
Google Scholar
PubMed
Search for other papers by A Ktorza in
Google Scholar
PubMed
Search for other papers by E Cerasi in
Google Scholar
PubMed
Search for other papers by G Leibowitz in
Google Scholar
PubMed
Search for other papers by N Kaiser in
Google Scholar
PubMed
Introduction Type 2 diabetes results from failure to increase insulin secretion in the face of insulin resistance ( Cerasi 1995 , Kahn 2003 ). Studies in humans and animal models of type 2 diabetes show marked β-cell dysfunction
Search for other papers by Sojin Lee in
Google Scholar
PubMed
Search for other papers by H Henry Dong in
Google Scholar
PubMed
mutations in FoxO genes or altered expression of FoxO proteins are associated with diseases including diabetes and cancer or with reduced lifespan in mammals. This latter aspect is exemplified by the illustration of role of the FoxO ortholog Daf16 in
Search for other papers by Sergio Di Meo in
Google Scholar
PubMed
Search for other papers by Susanna Iossa in
Google Scholar
PubMed
Search for other papers by Paola Venditti in
Google Scholar
PubMed
Introduction In recent years, the observation that insulin resistance (IR) and type 2 diabetes mellitus (T2DM) are growing dramatically all over the world has stimulated the research on such metabolic disorders and their possible therapy. At
Search for other papers by Thanh Q Dang in
Google Scholar
PubMed
Search for other papers by Nanyoung Yoon in
Google Scholar
PubMed
Search for other papers by Helen Chasiotis in
Google Scholar
PubMed
Search for other papers by Emily C Dunford in
Google Scholar
PubMed
Search for other papers by Qilong Feng in
Google Scholar
PubMed
Search for other papers by Pingnian He in
Google Scholar
PubMed
Search for other papers by Michael C Riddell in
Google Scholar
PubMed
Search for other papers by Scott P Kelly in
Google Scholar
PubMed
Search for other papers by Gary Sweeney in
Google Scholar
PubMed
potent effects on restricting endothelial transport ( Felinski & Antonetti 2005 , Witt & Sandoval 2014 ), and they contribute to the development of diabetes at least in part by increasing hepatic glucose production and reducing GLUT4 translocation in
Search for other papers by Ling He in
Google Scholar
PubMed
Search for other papers by Shumei Meng in
Google Scholar
PubMed
Division of Metabolism, Division of Endocrinology, Kennedy Krieger Institute, Departments of Pediatrics, Physiology and Medicine, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, Maryland 21287, USA
Search for other papers by Emily L Germain-Lee in
Google Scholar
PubMed
Search for other papers by Sally Radovick in
Google Scholar
PubMed
Search for other papers by Fredric E Wondisford in
Google Scholar
PubMed
Introduction Diabetes mellitus is increasing in prevalence worldwide due to dietary excesses and sedentary lifestyles. About 25.8 million individuals in the USA have diabetes, accounting for 8.3% of the population. Type 2 diabetes previously was
Search for other papers by Rachel K Meyer in
Google Scholar
PubMed
BIO5 Institute, University of Arizona, Tucson, Arizona, USA
Search for other papers by Frank A Duca in
Google Scholar
PubMed
GLP-1R activation ( Baggio et al. 2004 ). Further, oxyntomodulin production is blunted in individuals with type 2 diabetes (T2D) ( Wewer Albrechtsen et al. 2016 ), and treatment with oxyntomodulin is beneficial for glucose homeostasis via the
Chemical Biology and Therapeutics Program, Broad Institute of Harvard and MIT, Boston, Massachusetts, USA
Search for other papers by Morten Lundh in
Google Scholar
PubMed
Search for other papers by Marco Bugliani in
Google Scholar
PubMed
Search for other papers by Tina Dahlby in
Google Scholar
PubMed
Search for other papers by Danny Hung-Chieh Chou in
Google Scholar
PubMed
Search for other papers by Bridget Wagner in
Google Scholar
PubMed
Search for other papers by Seyed Mojtaba Ghiasi in
Google Scholar
PubMed
Search for other papers by Vincenzo De Tata in
Google Scholar
PubMed
Search for other papers by Zhifei Chen in
Google Scholar
PubMed
Department of Food Science, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Marianne Nissan Lund in
Google Scholar
PubMed
Search for other papers by Michael J Davies in
Google Scholar
PubMed
Search for other papers by Piero Marchetti in
Google Scholar
PubMed
Search for other papers by Thomas Mandrup-Poulsen in
Google Scholar
PubMed
animal models, and our study clarifies the translational potential of this concept, in that our data in human islets do not support the use of inhibitors selective for the i-proteasome in diabetes. In conclusion, beta cells upregulate immunoproteasome